GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $478.367M Est
GeneDx Holdings (NASDAQ: WGS ) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $478.367 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.